The drug lowers LDL-C through adenosine triphosphate-citrate lyase (ACL) inhibition. "Esperion snags US label expansion for cardiovascular disease drugs" was originally created and published by ...

Adenosine is a short-acting endogenous molecule that is a purine nucleoside. The half-life is 6 seconds. Adenosine receptor activation results in multiple different actions depending on the location.

We have been exploring the potential of the neuromodulator, adenosine, to reduce excessive dopamine signaling that contributes to the development and persistence of psychostimulant abuse. Dopamine’s ...